# Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers

> **NCT01436396** · PHASE3 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 792 (actual)

## Conditions studied

- Dengue
- Dengue Hemorrhagic Fever
- Yellow Fever

## Interventions

- **BIOLOGICAL:** Live, attenuated dengue serotype 1, 2, 3, and 4 virus
- **BIOLOGICAL:** Yellow fever vaccine
- **BIOLOGICAL:** Measles, mumps, and rubella (MMR) vaccine
- **BIOLOGICAL:** Pneumococcal Conjugated Vaccine
- **BIOLOGICAL:** Hepatitis A Pediatric Vaccine
- **BIOLOGICAL:** Diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae vaccine
- **BIOLOGICAL:** Live, attenuated dengue serotype 1, 2, 3, and 4 virus
- **BIOLOGICAL:** Yellow Fever Vaccine
- **BIOLOGICAL:** Placebo (NaCl)
- **BIOLOGICAL:** Measles, mumps, and rubella vaccine
- **BIOLOGICAL:** Pneumococcal Conjugated Vaccine
- **BIOLOGICAL:** Diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae vaccine
- **BIOLOGICAL:** Hepatitis A Pediatric Vaccine

## Key facts

- **NCT ID:** NCT01436396
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09-07
- **Primary completion:** 2013-09
- **Final completion:** 2013-09-02
- **Target enrollment:** 792 (ACTUAL)
- **Last updated:** 2022-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01436396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01436396, "Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01436396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*